TSPAN7 and diabetes mellitus: Furthermore, the presence of Tspan7 antibodies predicted a faster decline in pancreatic beta-cell function in Chinese LADA patients, demonstrating that the novel autoantibody marker has value in predicting metabolic outcomes in specific diabetes patient groups.